Les Authieux sur le Port Saint Ouen, France

Christophe Meyer

USPTO Granted Patents = 25 (Patent Applications = 2)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 9)

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 81(Granted Patents)

Location History:

Port St Ouen, FR (2008 - 2011)
Les Authieux s/l Port St Ouen, FR (2012)
Les Authieux sur le Port Saint, FR (2014)
Les Authieux s/l Port St Quen, FR (2014)
Les Authieux sur le Port Sain Ouen, FR (2015 - 2017)
Les Authieux sur le Port Saint Ouen, FR (2007 - 2018)
Issy-les Moulineaux, FR (2021)
Les Authieux sur le Port St Ouen, FR (2018 - 2022)

Company Filing History:

23 out of 2,078

Janssen Pharmaceutica Nv

patents

2 out of 66

Tibotec Pharmaceuticals Ltd.

patents

Years Active: 2007-2022

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11267804 - (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity (2022-03-08),

2. 11130751 - Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors (2021-09-28),

3. 10894793 - Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors (2021-01-19),

4. 10526316 - Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors (2020-01-07),

5. 10202387 - Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors (2019-02-12),

6. 10087187 - Imidazopyridazine derivatives as PI3KB inhibitors (2018-10-02),

7. 10077261 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer (2018-09-18),

8. 9598396 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors (2017-03-21),

9. 9150540 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as parp and tubulin polymerization inhibitors (2015-10-06),

10. 8889866 - Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors (2014-11-18),

11. 8883837 - Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication (2014-11-11),

12. 8778966 - Quinolinone derivatives as PARP and tank inhibitors (2014-07-15),

13. 8404713 - Quinolinone derivatives as PARP inhibitors (2013-03-26),

14. 8404683 - Inhibitors of the interaction between MDM2 and P53 (2013-03-26),

15. 8377961 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 (2013-02-19),

Title: Christophe Meyer - Innovative Inventor from Les Authieux sur le Port Saint Ouen, FR

Introduction: Christophe Meyer is a renowned inventor hailing from Les Authieux sur le Port Saint Ouen, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Christophe Meyer holds several patents in the areas of renewable energy, sustainable agriculture, and smart home technologies, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Christophe Meyer has worked with leading research institutions and tech companies, developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Christophe Meyer has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the successful implementation of numerous groundbreaking projects.

Conclusion: Christophe Meyer's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

This text is generated by artificial intelligence and may not be accurate.